LB Pharmaceuticals Inc(LBRX)
Pharmaceuticals
CNS / Psychiatry Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-10 | KROIN DAVID 10% Owner | Purchase | +472,369 | +100.00%472,369 | $21.17 | $10,000,004 | View SEC filing | |
| 2025-09-16 | KROIN DAVID 10% Owner | Purchase | +2,666,666 | +388.65%3,352,804 | $15.00 | $39,999,990 | View SEC filing | |
| 2025-09-16 | Pontifax Management 4 G.P. (2015) Ltd. 10% Owner | Purchase | +1,000,000 | +121.45%1,823,362 | $15.00 | $15,000,000 | View SEC filing | |
| 2025-09-16 | Nussbaum Ran Director | Purchase | +1,000,000 | +121.45%1,823,362 | $15.00 | $15,000,000 | View SEC filing | |
| 2025-09-16 | Belldegrun Arie 10% Owner | Purchase | +333,333 | +60.73%882,243 | $15.00 | $4,999,995 | View SEC filing |
1-5 of 5